These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 738649)

  • 21. Effect of pulsed estrogen therapy on hemostatic markers in comparison with oral estrogen regimen in postmenopausal women.
    Basurto L; Saucedo R; Zárate A; Martínez C; Gaminio E; Reyes E; Hernandez M
    Gynecol Obstet Invest; 2006; 61(2):61-4. PubMed ID: 16192735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytotoxicity and effects of T2-toxin on plasma proteins involved in coagulation, fibrinolysis and kallikrein-kinin system.
    Johnsen H; Odden E; Johnsen BA; Bøyum A; Amundsen E
    Arch Toxicol; 1988 Jan; 61(3):237-40. PubMed ID: 3281632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in coagulation and fibrinolysis variables during use of two oral contraceptives containing the same dose of ethinyl estradiol and either gestodene or desogestrel.
    Gevers Leuven JA; Kluft C; Dersjant-Roorda MC; Harthoorn-Lasthuizen EJ; Peters FP; Bernsen MJ; Helmerhorst FM
    Adv Contracept; 1990 Dec; 6 Suppl():69-73. PubMed ID: 2149807
    [No Abstract]   [Full Text] [Related]  

  • 24. Cold activation of complement and kinin.
    Kondo M; Takemura S; Yoshikawa T; Kato H; Yokoe N; Ikezaki M; Hosokawa K; Masuda M
    Adv Exp Med Biol; 1979; 120B():133-8. PubMed ID: 117680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of either tibolone or continuous combined transdermal estradiol with medroxyprogesterone acetate on coagulatory factors and lipoprotein(a) in menopause.
    Perrone G; Capri O; Galoppi P; Brunelli R; Bevilacqua E; Ceci F; Ciarla MV; Strom R
    Gynecol Obstet Invest; 2009; 68(1):33-9. PubMed ID: 19349712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of two oral contraceptives, containing 30 or 20 microg of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women.
    Ferreira AC; Montes MB; Franceschini SA; Toloi MR
    Int J Fertil Womens Med; 2001; 46(5):265-70. PubMed ID: 11720199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of blood coagulation, fibrinolytic and kallikrein systems during storage of plasma.
    Blombäck M; Chmielewska J; Netré C; Akerblom O
    Vox Sang; 1984; 47(5):335-42. PubMed ID: 6209855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood coagulation with a combination pill containing gestodene and ethinyl estradiol.
    Bonnar J; Daly L; Carroll E
    Int J Fertil; 1987; 32 Suppl():21-8. PubMed ID: 2906344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of oral contraceptive estrogen on blood coagulation and fibrinolysis.
    Hedlin AM
    Thromb Diath Haemorrh; 1975 Apr; 33(2):370-8. PubMed ID: 1138426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Balance of coagulation activity with fibrinolysis during use of oral contraceptives in women with insulin-dependent diabetes mellitus.
    Petersen KR; Skouby SO; Jespersen J
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():105-11. PubMed ID: 8574252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Control of coagulation and fibrinolysis by plasma proteinase inhibitors.
    Travis J; Salvesen G
    Behring Inst Mitt; 1983 Aug; (73):56-65. PubMed ID: 6206838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on coagulation, fibrinolysis, kallikrein-kinin and complement activation in systemic and pulmonary circulation during hip arthroplasty with acrylic cement.
    Dahl OE; Molnar I; Vinje A; Rø JS; Kierulf P; Andersen AB; Dalaker K; Prydz H
    Thromb Res; 1988 Jun; 50(6):875-84. PubMed ID: 3413734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coagulation and fibrynolitic parameters in women and the effects of hormone therapy; comparison of transdermal and oral administration.
    Połać I; Borowiecka M; Wilamowska A; Nowak P
    Gynecol Endocrinol; 2013 Feb; 29(2):165-8. PubMed ID: 23116237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coagulation studies of menopausal women taking estrogen replacement.
    Beller FK; Nachtigall L; Rosenberg M
    Obstet Gynecol; 1972 May; 39(5):775-8. PubMed ID: 4260072
    [No Abstract]   [Full Text] [Related]  

  • 38. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Blood coagulation, fibrinolysis, kallikrein-kinin system and treatment of their disorders].
    Ogata H
    Masui; 1975 May; 24(5):479-85. PubMed ID: 1172022
    [No Abstract]   [Full Text] [Related]  

  • 40. Cold promoted activation of Factor VII. Occurrence and relation to sex hormones and antifertility compounds.
    Gjonnaess H
    Gynecol Invest; 1973; 4(2):61-72. PubMed ID: 4128167
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.